Risk Factors of Blood Culture Positivity and Mortality in Bloodstream Infections: A Population‐Based Study of Patients With B‐Cell Malignancies
Authors:
- Mathias Holmsgaard EskesenMEMathias Holmsgaard Eskesen
- Alexander Djupnes FuglkjærAFAlexander Djupnes Fuglkjær
- Tarec Christoffer El‐GalalyTETarec Christoffer El‐Galaly
- Paw JensenPJPaw Jensen
- Izabela Ewa NielsenINIzabela Ewa Nielsen
- Laurids Østergaard PoulsenLPLaurids Østergaard Poulsen
- Mikkel Runason SimonsenMSMikkel Runason Simonsen
- Kirstine Kobberøe SøgaardKSKirstine Kobberøe Søgaard
Open Access
- 19 June 2026
- journal article
- research article
- Published by Wiley in European Journal of Haematology
- Vol. 117 (4) , 1061-1071
Abstract
Background: Bloodstream infections remain a major cause of mortality among cancer patients. Pathogen surveillance and risk stratification tools are key to improved management. This study describes trends in causative pathogens and explores risk factors for positive blood cultures (PBCs) and post‐infection mortality in cancer patients. Methods: We performed a cohort study of patients diagnosed with a B‐cell malignancy in the North Denmark Region between 2013 and 2022, linking cancer registry data to health records. Causative pathogens were described. LASSO regression was used to select variables associated with PBCs and post‐infection mortality. Odds ratios were estimated by univariate analyses. Results: Among 1592 patients with B‐cell malignancies, 341 patients (21.4%) had at least one PBC, yielding 484 PBCs. We observed a shift from Gram‐positive to Gram‐negative dominance, driven by an increased frequency of the most common pathogen Escherichia coli (24.8%). Patients with neutropenia, elevated CRP, sepsis, hypotension, or kidney failure had a higher risk of a PBC. Advanced age, kidney failure, and sepsis were all associated with 30‐ and 90‐day post‐infection mortality. Conclusion: Routinely available parameters obtained at time of admission were associated with blood culture positivity and mortality. Our findings support the rationale for developing predictive models to individualise infection management.Keywords
Funding Information
- Danish Data Science Academy (2023‐1210)
This publication has 21 references indexed in Scilit:
- Epidemiology of resistant bacterial infections in patients with hematological malignancies or undergoing hematopoietic cell transplantation in Europe: A systematic review by the European Conference on Infections in Leukemia (ECIL)Journal of Infection, 2025
- Factors Increasing the Risk of Infection in Patients With Multiple Myeloma: From Biology to PreventionClinical Lymphoma Myeloma and Leukemia, 2025
- Causes of death among patients diagnosed with chronic lymphocytic leukemia: A population‐based study in the Netherlands, 1996–2020HemaSphere, 2024
- What more do you need? Safety of early oral antimicrobials for low-risk neutropenic patients with suspected infectionClinical Microbiology and Infection, 2023
- Early switch to oral antibiotic therapy in patients with low-risk neutropenic sepsis (EASI-SWITCH): a randomized non-inferiority trialClinical Microbiology and Infection, 2023
- Bloodstream infections in cancer patients. Risk factors associated with mortalityInternational Journal of Infectious Diseases, 2018
- Epidemiology of bloodstream infections in patients with myeloma receiving current era therapyEuropean Journal of Haematology, 2016
- The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)JAMA, 2016
- Increase in Bloodstream Infection Due to Vancomycin-Susceptible Enterococcus faecium in Cancer Patients: Risk Factors, Molecular Epidemiology and OutcomesPLOS ONE, 2013
- Factors associated with mortality in bacteremic patients with hematologic malignanciesDiagnostic Microbiology and Infectious Disease, 2009